$64.68 0.08 (+0.12%)
2/13/2012 4:01 PM

Johnson & Johnson (NYSE:JNJ)

CAPS Rating: 5 out of 5

A vast and diverse health care giant, Johnson & Johnson strives to help people get well through its consumer products, pharmaceuticals, and medical devices.

Recs

1
Player Avatar SafeAndCheap (99.54) Submitted: 9/21/2008 9:19:46 PM : Outperform Start Price: $56.86 JNJ Score: +12.74

I don't like investing in individual pharma companies as a rule: too much risk in any individual company. J&J is the exception; it's a bit like owning a pharma ETF. Plus it's one of the world's better run companies. You won't hit a home run, but with reinvested dividends, you'll earn a respectable return over time. Sleep at night with J&J.

Report this Post Add Comment

Featured Broker Partners


Advertisement